SCHEMBL5206015

SCHEMBL5206015

Nc1ncc(Oc2ccc(Cl)cc2)c(NC[C@@H]2CCC[C@@H]2O)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 4/20 0.41
IDO1 P14902 3/20 0.36
TNK2 Q07912 1/20 0.36
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
KCNH2 Q12809 2/20 0.34
SCN9A Q15858 2/20 0.34
SCN5A Q14524 1/20 0.34
CCNT1 O60563 1/20 0.34
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34
CDK9 P50750 1/20 0.34
IRAK1 P51617 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TRPC6 Q9Y210 1/20 0.34
CNR2 P34972 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1376200 1.00 TDO2 (0.41) TDO2IDO1TNK2PDCD1CD274
SCHEMBL1376197 1.00 TDO2 (0.41) TDO2IDO1TNK2PDCD1CD274
SCHEMBL5205113 0.98 TDO2 (0.43) TDO2IDO1TNK2PDCD1CD274
SCHEMBL1377884 0.98 TDO2 (0.43) TDO2IDO1TNK2PDCD1CD274
SCHEMBL1377882 0.98 TDO2 (0.43) TDO2IDO1TNK2PDCD1CD274
SCHEMBL1378922 0.94 SCN9A (0.36) TDO2TNK2KCNH2SCN9ASCN5A
SCHEMBL5203626 0.94 SCN9A (0.36) TDO2TNK2KCNH2SCN9ASCN5A
SCHEMBL1378923 0.94 SCN9A (0.36) TDO2TNK2KCNH2SCN9ASCN5A
SCHEMBL1375389 0.92 TDO2 (0.36) TDO2IDO1TNK2PDCD1CD274
SCHEMBL1375388 0.92 TDO2 (0.36) TDO2IDO1TNK2PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed